Advertisement

Enovis Corporation ENOV

Set alert

Price alert · ENOV

All alert types
19.91 USD -2.90 -12.71%

At close · Oct 30

19.85 -0.06 -0.30%

After hours · Oct 30, 5:57 PM ET

Bid
19.76 × 700
Ask
19.97 × 800
19.83 Day range 22.26
17.43 52-week range 31.51
YTD
-25.26%
1 year
-35.13%
Open
22.17
Prev close
22.81
Mkt cap
1.15B
Vol
2.52M
Avg vol
1.54M
EPS
-19.23
P/E
0.00
Div yield
0.00%
More statistics
Low
19.83
High
22.26
Forward P/E
5.64
Beta
1.48
Short ratio
7.14
Inst. own
119.13%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
20.13
200-d avg
23.09
1y target
36.08

2Y chart

Chart tools
Interval

Events in this range
  • Aug 7, 2025Earnings: 0.79; estimate 0.74; surprise 6.76%
  • Nov 6, 2025Earnings: 0.75; estimate 0.67; surprise 11.94%
  • Feb 26, 2026Earnings: 0.95; estimate 0.81; surprise 17.28%
  • May 7, 2026Earnings: 0.89; estimate 0.82; surprise 8.54%
  • Aug 6, 2026Earnings: 0.9; estimate 0.847; surprise 6.26%
  • Aug 17, 2026Rating: Canaccord Genuity · Buy → Buy
  • Sep 1, 2026Rating: BTIG · Buy → Buy
  • Sep 2, 2026Rating: Freedom Capital Markets · Buy → Buy
  • Sep 2, 2026Rating: Citizens · Market Outperform → Market Outperform
  • Sep 2, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 12, 2026Rating: Needham · Buy → Buy
Signals (97)
NameDateAgo
SMA: BearishOct 30, 20262 days ago
RSI: OverboughtOct 29, 20263 days ago
SMA: BullishOct 20, 20261 week ago
MACD: Buy SignalSep 23, 20261 month ago
RSI: OversoldSep 10, 20261 month ago
RSI: OversoldSep 2, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BearishAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BearishAug 10, 20262 months ago
MACD: Sell SignalAug 6, 20262 months ago
SMA: BullishJul 16, 20263 months ago
SMA: BearishJul 14, 20263 months ago
SMA: BullishJul 10, 20263 months ago
SMA: BearishJul 7, 20263 months ago
SMA: BullishJul 6, 20263 months ago
SMA: BullishJul 6, 20263 months ago
MACD: Buy SignalJul 2, 20264 months ago
MACD: Sell SignalJul 1, 20264 months ago
MACD: Buy SignalJun 25, 20264 months ago
SMA: BearishMay 27, 20265 months ago
MACD: Sell SignalMay 21, 20265 months ago
SMA: BearishMay 8, 20265 months ago
SMA: BullishMay 7, 20265 months ago
MACD: Buy SignalMay 7, 20265 months ago
SMA: BullishMay 5, 20266 months ago
SMA: BearishApr 28, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 23, 20266 months ago
MACD: Sell SignalApr 23, 20266 months ago
SMA: BullishApr 8, 20266 months ago
SMA: BearishApr 2, 20267 months ago
MACD: Buy SignalApr 2, 20267 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BearishMar 27, 20267 months ago
SMA: BullishMar 26, 20267 months ago
MACD: Sell SignalMar 13, 20267 months ago
SMA: BearishMar 12, 20267 months ago
SMA: BullishMar 11, 20267 months ago
SMA: BearishMar 10, 20267 months ago
SMA: BullishFeb 26, 20268 months ago
MACD: Buy SignalFeb 6, 20268 months ago
RSI: OversoldJan 27, 20269 months ago
MACD: Sell SignalJan 14, 20269 months ago
SMA: BearishJan 12, 20269 months ago
SMA: BullishJan 8, 20269 months ago
MACD: Buy SignalDec 22, 202510 months ago
MACD: Sell SignalDec 4, 202511 months ago
MACD: Buy SignalNov 26, 202511 months ago
SMA: BearishNov 12, 202511 months ago
SMA: BullishNov 11, 202511 months ago
SMA: BearishNov 6, 202512 months ago
SMA: BullishNov 4, 202512 months ago
SMA: BearishOct 30, 20251 year ago
MACD: Sell SignalOct 30, 20251 year ago
MACD: Buy SignalOct 17, 20251 year ago
SMA: BullishOct 14, 20251 year ago
SMA: BearishOct 10, 20251 year ago
MACD: Sell SignalSep 23, 20251 year ago
SMA: BullishAug 22, 20251 year ago
SMA: BearishAug 20, 20251 year ago
SMA: BullishAug 19, 20251 year ago
MACD: Buy SignalAug 7, 20251 year ago
RSI: OversoldJul 18, 20251 year ago
MACD: Sell SignalJul 15, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishJul 8, 20251 year ago
SMA: BearishJul 7, 20251 year ago
SMA: BullishJul 2, 20251 year ago
MACD: Buy SignalJun 25, 20251 year ago
MACD: Sell SignalJun 18, 20251 year ago
MACD: Buy SignalJun 9, 20251 year ago
MACD: Sell SignalMay 21, 20251 year ago
SMA: BearishMay 20, 20251 year ago
SMA: BullishMay 12, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
MACD: Sell SignalApr 3, 20251 year ago
RSI: OversoldApr 3, 20251 year ago
MACD: Buy SignalMar 17, 20251 year ago
RSI: OversoldMar 10, 20251 year ago
RSI: OversoldFeb 26, 20251 year ago
SMA: BearishFeb 6, 20251 year ago
SMA: BullishFeb 4, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
MACD: Sell SignalFeb 3, 20251 year ago
SMA: BullishJan 17, 20251 year ago
MACD: Buy SignalJan 8, 20251 year ago
RSI: OverboughtNov 27, 20241 year ago
RSI: OverboughtNov 25, 20241 year ago

Key statistics

Market cap
1.15B
Enterprise value
2.67B
Trailing P/E
0.00
Forward P/E
5.64
PEG ratio
3.45
Price / sales
0.50
Price / book
0.78
EPS (TTM)
-19.23
Beta
1.48
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-47.97%
Revenue (TTM)
2.30B
Revenue growth
3.20%
Free cash flow
185.94M
Total cash
12.56M
Total debt
1.37B
Return on equity
-54.14%
Shares outstanding
57.67M
Short % of float
24.18%
50-day average
20.13
200-day average
23.09

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 36.08 +81.2% upside
Target (low)
24.00
Target (mean)
36.08
Target (high)
47.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy10
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 0.76681.

Earnings history

Financials — quick view

All financials
ENOV Revenue — quarterly 582.78M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ENOV Net income — quarterly -1.19M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ENOV EPS — quarterly -0.02
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ENOV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Oct 3, 20260.767———
Aug 6, 2026Jul 3, 20260.8470.90+0.05+6.26%
May 7, 2026Apr 3, 20260.820.89+0.07+8.54%
Feb 26, 2026Dec 31, 20250.810.95+0.14+17.28%
Nov 6, 2025Oct 3, 20250.670.75+0.08+11.94%
Aug 7, 2025Jul 4, 20250.740.79+0.05+6.76%

Upgrades / downgrades

ENOV analyst upgrades and downgrades
DateFirmActionFromTo
Oct 12, 2026NeedhammainBuyBuy
Sep 2, 2026Wells FargomainOverweightOverweight
Sep 2, 2026CitizensmainMarket OutperformMarket Outperform
Sep 2, 2026Freedom Capital MarketsmainBuyBuy
Sep 1, 2026BTIGmainBuyBuy
Aug 17, 2026Canaccord GenuitymainBuyBuy

About Enovis Corporation

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
enovis.com

News

Your note

Sign in to keep a note on ENOV — it syncs with the Stock Master app.

Insider holders

ENOV insider holders
InsiderRelationLatest transactionDateShares held
BERRY PHILLIP BENJAMIN BENChief Financial OfficerStock Award(Grant)Mar 8, 2026158,596
ENGERT OLIVEROfficerPurchaseSep 3, 202663,898
LANG PATRICIA AOfficerStock Award(Grant)Mar 8, 202675,703
MCDONALD DAMIENChief Executive OfficerPurchaseSep 3, 2026247,077
PRYOR DANIEL ALEXISFormerSaleDec 8, 20250
ROSS TERRY DOfficerStock Award(Grant)Mar 8, 202668,477

Institution ownership

ENOV institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.85%10,295,666205.91MJun 29, 2026
American Century Companies Inc10.59%6,106,561122.13MJun 29, 2026
Vanguard Portfolio Management LLC6.81%3,926,26878.53MJun 29, 2026
Rubric Capital Management LP6.76%3,900,00078.00MJun 29, 2026
Vanguard Capital Management LLC4.31%2,484,31849.69MJun 29, 2026
State Street Corporation4.27%2,462,78849.26MJun 29, 2026

Fund ownership

ENOV fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%3,431,56968.63MSep 29, 2026
American Century Capital Portfolios, Inc.-Small Cap Value Fund4.54%2,620,00052.40MJun 29, 2026
Fidelity Securities Fund-Fidelity Small Cap Value Fund4.04%2,328,36046.57MJul 30, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF3.80%2,189,18243.78MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.98%1,719,53034.39MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.59%1,493,64329.87MSep 29, 2026
Advertisement